ImmuCell Earnings & Forecasts - Benzinga

ImmuCell Corp

ICCCNASDAQ

Trade with Public

Trade with Public

$10.75

0.191.8%

最終更新: Oct 14, 9:15 AM

$11.05

0.494.6%

概要ニュース業績予想イベント財務センチメント株主構成比較株式レポート

ImmuCell Earnings & Forecasts - Benzinga

ImmuCell Earnings & Forecasts

ImmuCell (ICCC) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

ImmuCell Guidance

ImmuCell (ICCC) は、10 14, 2026日にQ3の2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$8M - $8Mの範囲と予想しています。

以前のガイダンスと比較して、ImmuCellは売上高予測を以前の範囲である維持から$8M - $8Mに引き上げました。

ImmuCellは、22から1 9, 2023の間に10 14, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 9 times and lowered it 11 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	—	—	—	—
Actual	$0.20	$0.21	$-0.31	$-0.02
Surprise	—	—	—	—
Revenue
Estimate	—	—	—	—
Actual	$7.2M	$10.4M	$7.6M	$5.5M
Surprise	—	—	—	—

Earnings & Guidance News

PRO
ImmuCell Sees Q3 Sales $8.000M

ImmuCell (NASDAQ:ICCC) sees Q3 sales of $8.000 million.

Benzinga Newsdesk

PRO
ImmuCell Reports Q3 Preliminary Sales Of $8M, Up 46% YoY

ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity,

Benzinga Newsdesk

PRO
ImmuCell Q2 EPS $0.20 Up From $0.06 YoY, Sales $7.186M Up From $6.445M YoY

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.20 per share. This is a 233.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $7.186 million in sales

Benzinga Newsdesk

PRO
ImmuCell Q2 Total Product Sales Rises 12%

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity,

Benzinga Newsdesk

PRO
ImmuCell Q1 EPS $0.21 Up From $0.16 YoY, Sales $10.357M Up From $8.067M YoY

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.21 per share. This is a 31.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported $10.357 million in sales this

Benzinga Newsdesk

Earnings Scheduled For May 14, 2026

Benzinga Insights

四半期売上高の驚きの金額

会計四半期	報告日	実際の収益	推定収益	驚き％
Q2	Aug 13, 2024	$5.47M	$3.26M	67.9 %
Q3	Nov 21, 2022	$4.80M	$5.40M	-11.2 %
Q1	May 12, 2022	$6.00M	$5.40M	11.1 %
Q4	Feb 22, 2022	$5.44M	$5.40M	0.81 %